Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro

Bioorg Med Chem. 2002 Dec;10(12):3725-30. doi: 10.1016/s0968-0896(02)00379-6.

Abstract

Twenty-seven oxygenated xanthones have been assessed for their capacity to inhibit in vitro the growth of three human cancer cell lines, MCF-7 (breast cancer), TK-10 (renal cancer) and UACC-62 (melanoma). The effect of these xanthones on the proliferation of human T-lymphocytes was also evaluated. Differences on their potency towards the effect on the growth of the human cancer cell lines as well as on the proliferation of human T-lymphocytes can be ascribed to the nature and positions of the substituents on the xanthonic nucleus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / chemical synthesis
  • Adjuvants, Immunologic / pharmacology
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology
  • Cell Division / drug effects
  • Drug Screening Assays, Antitumor
  • Humans
  • Inhibitory Concentration 50
  • Lymphocyte Activation / drug effects*
  • Phytohemagglutinins / pharmacology
  • Structure-Activity Relationship
  • T-Lymphocytes / drug effects
  • Tumor Cells, Cultured
  • Xanthenes / chemical synthesis
  • Xanthenes / pharmacology*
  • Xanthones*

Substances

  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Phytohemagglutinins
  • Xanthenes
  • Xanthones
  • xanthone